|1.||Seward, Jane F: 23 articles (03/2014 - 02/2002)|
|2.||Centers for Disease Control and Prevention (CDC): 21 articles (10/2014 - 02/2000)|
|3.||Schmid, D Scott: 17 articles (12/2013 - 11/2003)|
|4.||Gershon, Anne A: 14 articles (04/2015 - 02/2004)|
|5.||Kuter, Barbara J: 12 articles (12/2014 - 04/2002)|
|6.||Marin, Mona: 9 articles (12/2013 - 02/2007)|
|7.||Black, Steve: 8 articles (07/2014 - 02/2004)|
|8.||Jumaan, Aisha O: 8 articles (01/2010 - 02/2002)|
|9.||Ozaki, Takao: 7 articles (12/2013 - 09/2003)|
|10.||Schödel, Florian: 7 articles (12/2011 - 08/2005)|
03/01/2008 - "When administered after exposure, varicella vaccine was highly effective in preventing or modifying varicella. "
12/02/2004 - "The varicella vaccine Varilrix may not be effective in preventing varicella when administered after household exposure, although it is highly effective in ameliorating the disease in those who acquire it under these circumstances."
01/01/2000 - "When used within 36 hours after exposure to varicella in a setting where close contact occurred, varicella vaccine was highly effective in preventing further disease. "
11/12/1997 - "Varicella vaccine administered under routine conditions in physicians' offices was highly effective in preventing varicella in an outbreak characterized by intense exposure. "
05/01/1995 - "A live, attenuated varicella vaccine developed in 1974 and unlicensed in the United States is safe and highly effective in preventing varicella in healthy and immunocompromised populations. "
09/01/1984 - "One-hundred-ninety-one children with acute leukemia in remission for at least one year were immunized with 1 or more doses of live attenuated varicella vaccine. "
11/01/1996 - "Varicella vaccine in immunocompromised children was clinically evaluated in 575 US and Canadian children with leukemia in remission by the Varicella Vaccine Collaborative Study. "
09/01/1984 - "The results suggest that the varicella vaccine is effective in children with acute leukemia, and that long-term effectiveness can be expected."
09/01/1996 - "A review of the use of live attenuated varicella vaccine in immunocompromised children, particularly those with underlying leukemia in remission, is presented. "
10/01/1986 - "Live attenuated varicella vaccine has been administered to 307 children with leukemia in remission and to 86 healthy adults. "
04/01/2012 - "Studies suggest that varicella vaccine is well tolerated and immunogenic in moderately immunocompromised children and could be beneficial in reducing the burden of viral infection. "
01/01/2014 - "This study aims to evaluate the determinants of breakthrough infection after one dose of varicella vaccine. "
12/01/2010 - "In this review, we summarized recent studies on 1) animal models for VZV infection and outcomes from studies using the models, including 2) viral dissemination processes from respiratory mucosa, T cells, to skin, 3) cellular receptors for VZV entry, 4) functions of viral genes required uniquely for in vivo growth and for establishment of latency, 5) host immune responses and viral immune evasion mechanisms, and 6) varicella vaccine and anti-VZV drugs."
05/01/2014 - "Among 152 patients between 1 and 15 years of age, 139 children received varicella vaccine and all had breakthrough infections. "
12/01/2013 - "Genotyping of wild type of varicella zoster virus (VZV) in Sri Lanka would help to distinguish the VZV wild type infection from varicella vaccine associated infections. "
08/01/1995 - "To estimate the efficacy of varicella vaccine for protection against herpes zoster in the elderly, we investigated the incidence of herpes zoster in 500 pediatricians and family practitioners with their fifties and sixties, and history of reexposure to VZV in 61 patients with herpes zoster by questionnaires retrospectively. "
03/01/2010 - "The aim of this study was to investigate the effects of race, chronic medical conditions and treatments, and recent vaccination, on the risk of herpes zoster (HZ) in children vaccinated with one dose of varicella vaccine. "
01/01/2005 - "Further studies are needed to understand secular trends in herpes zoster before and after use of varicella vaccine in the United States and other countries."
01/01/2002 - "However, the best prevention of PHN is the prevention of herpes zoster disease, and the varicella vaccine is an option which over the next few years will be tested in clinical trials. "
09/01/2001 - "The goals of ongoing studies in herpes zoster are to develop interventions that will further reduce the symptoms of PHN and/or to eliminate PHN by prophylaxis using the varicella vaccine. "
|5.||Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/21/1993 - "Change in source of information: availability of varicella vaccine for children with acute lymphocytic leukemia."
07/02/1993 - "Change in source of information: availability of Varicella vaccine for children with acute lymphocytic leukemia."
08/01/1992 - "Availability of varicella vaccine for children with acute lymphocytic leukemia."
06/10/1992 - "Availability of varicella vaccine for children with acute lymphocytic leukemia."
06/01/1994 - "A 5-year-old white boy in remission from acute lymphoblastic leukemia who was receiving maintenance anticancer chemotherapy had approximately 200 vesicular skin lesions 1 month after receiving live attenuated varicella vaccine. "
|1.||Chickenpox Vaccine (Vaccine, Varicella)
|2.||Measles-Mumps-Rubella Vaccine (MMR Vaccine)
|3.||varicella vaccine rubella mumps measles
|5.||Herpes Zoster Vaccine
|6.||Hepatitis B Vaccines (Hepatitis B Vaccine)
|7.||A 7 (A-7)
|1.||Drug Therapy (Chemotherapy)
|3.||Day Care (Partial Hospitalization)